Error: Could not add to watchlist. X
+ Watchlist

Santarus Inc

SNTS:US
Acquired
SNTS:US was acquired by 0072162D:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
2.36
Market Cap (USD)
-
Shares Outstanding (m)
67.129
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Santarus, Inc. focuses on acquiring, developing, and commercializing proprietary products. The Company offers budesonide, bromocriptine mesylate, fenofibrate, omeprazole, and metformin hydrochloride extended release tablets. Santarus operates in the State of California.
Address
12230 El Camino Real
Suite 300
San Diego, CA 92130
United States
Phone
1-858-314-5700
Website
-
Show More